A cosmetic compliance checklist gives a new beauty brand a disciplined way to confirm product classification, safety evidence, labels, responsible parties, notifications and post-market controls before a product is supplied in each target market. There is no universal “global approval”: the required route changes by country, product, claims and supply chain role.
Why a cosmetic compliance checklist matters
For a new beauty brand, the most expensive compliance error is often made before the first production batch: treating a certificate, portal submission or factory document as a universal permission to sell. A cosmetic can be lawful in one destination while another destination requires a different responsible person, notification timing, label language or product file. Use this checklist as a launch-control document, then validate the current rules with the relevant authority or qualified compliance professional.
1. Define the product and the markets first
Start with the exact finished product, not a broad product idea. Record its intended use, application area, target customer, claims, formula version, fragrance or shade variants, pack sizes and destination markets. A claim can alter the regulatory assessment: language that implies treatment, prevention or a physiological effect may need separate review from a cosmetic claim.
| Launch question | Why it matters | Evidence to retain |
|---|---|---|
| Where will the product be supplied? | Each market can have its own notification, local representative and label rules. | Country list, launch dates and channel plan. |
| What is the intended cosmetic use? | Classification should be checked before claims, artwork and testing are finalised. | Product brief, claims matrix and label draft. |
| Which formula and variants are covered? | Formula or concentration changes may require a new review or notification update. | Controlled formula, INCI list and change log. |
2. Assign who is responsible for market access
Brand owner, importer, distributor and manufacturer responsibilities are not interchangeable. The party named on a label, the party placing a product on a market and the party maintaining a product file can each matter. Set roles in writing before artwork is approved.
| Manufacturer can normally provide | Brand owner or responsible party must decide |
|---|---|
| Formula and INCI-related information | Target markets, product positioning and claims |
| Batch records, COA, SDS and quality records where applicable | Who acts as Responsible Person, importer or notifier |
| Stability, microbiological and compatibility information available for the product | Final label, translations, notifications and market-specific files |
| Manufacturing and technical-documentation support | Ongoing change control and post-market reporting arrangements |
For example, FDA describes the MoCRA “responsible person” as the manufacturer, packer or distributor whose name appears on the cosmetic label. In the EU and Great Britain, the Responsible Person concept has market-specific duties that should be assessed for the exact supply model.
3. Build the safety and technical evidence file
Do not wait until a buyer, distributor or authority asks for documents. Establish a controlled file for each finished product and preserve the version used at launch. The exact legal file varies by market, but a practical working checklist includes:
- approved formula and quantitative composition controls;
- INCI list and ingredient restrictions assessment for each target market;
- finished-product specifications and test plan;
- stability, microbiological quality and packaging-compatibility evidence appropriate to the product;
- manufacturing, batch and quality records;
- label artwork, claims substantiation and a change-control log;
- the name and contact details of the party holding the applicable product information.
In Great Britain, GOV.UK states that the Responsible Person must ensure a safety assessment is carried out by a suitably qualified safety assessor and must submit product information before the product is made available. In the EU, the European Commission states that Regulation (EC) No 1223/2009 requires specified information to be submitted through CPNP by responsible persons and, in certain circumstances, distributors.
4. Check the destination-market route before launch
| Market example | Core checkpoint | Practical launch question |
|---|---|---|
| United States | FDA registration and product listing can apply under MoCRA, subject to defined exemptions. | Is the facility or responsible person required to register or list, and are annual updates planned? |
| European Union | CPNP is the EU notification system under Article 13 of Regulation (EC) No 1223/2009. | Has the Responsible Person confirmed the product file, safety report, label and notification route? |
| Great Britain | A Responsible Person and notification to OPSS are required before products are made available in GB. | Does the UK Responsible Person hold the required information and has SCPN notification been completed? |
| Canada | Manufacturers and importers must submit a Cosmetic Notification Form within 10 days of first sale. | Who will file, and how will brand, formula and contact changes be controlled? |
These are not interchangeable processes. FDA says facility registration and product listing are not a cosmetic approval program and are not a promotional certificate. Likewise, an EU CPNP notification does not itself replace other legal duties such as the appropriate product file, safety work, label or Responsible Person arrangements.
5. Approve the label as a controlled compliance record
Use a market-by-market label checklist before printing. Check the product name and function, ingredient declaration, warnings, quantity, batch or identification code, durability information where required, country-of-origin statements when applicable, and the name and address required for the responsible party. Confirm language and claim requirements for every destination. Never copy a label from one market to another without a scoped review.
6. Complete notification, registration or listing at the right time
Build the regulatory calendar around the actual trigger. The EU Commission explains that a CPNP notification removes the need for further national notification within the EU. GOV.UK states that products made available in Great Britain must be notified to OPSS before they are made available. Health Canada explains that a Cosmetic Notification Form is due within 10 days after first sale. FDA’s current information should be consulted for the applicable MoCRA registration and listing requirements and exemptions.
- Lock the formula, claims and label version.
- Confirm the legal role that submits or maintains the required information.
- Submit only the information that matches the controlled product version.
- Store confirmation records with the product file.
- Define how formula, label, name, contact and facility changes will be assessed and updated.
7. Plan post-market responsibilities before the first sale
Compliance continues after launch. Set a practical process for complaints, adverse-event escalation, batch traceability, distributor feedback, recall decisions and records retention. The responsible business should know who receives safety reports, who reviews trend signals and who can stop distribution if a material issue is identified.
Common mistakes new brands can avoid
- Calling notification, listing or facility registration “product approval.”
- Assuming a manufacturer certificate replaces destination-market obligations.
- Approving artwork before the local responsible party and label requirements are known.
- Using a formula revision without reassessing the file, claims or notification.
- Leaving post-market complaints and batch traceability outside the launch plan.
FAQs
Is there one global cosmetic compliance certificate?
No. A voluntary certificate may be commercially useful, but market access usually depends on destination-specific legal obligations, product evidence, labelling and notification or registration requirements.
Does FDA registration mean a cosmetic is approved?
No. FDA states that cosmetic facility registration and product listing are not a cosmetic approval program and do not result in FDA certificates.
Who should hold the compliance file?
That depends on the market and supply model. Agree the holder, access rights and update process before launch; in some markets the Responsible Person has specific file duties.
What should an OEM or ODM manufacturer provide?
A manufacturer can provide agreed technical and quality documentation, but the brand and responsible party must confirm destination-market legal duties, claims, labels and notifications.
What MOOYAM can provide
MOOYAM provides cosmetic OEM/ODM manufacturing and technical-documentation support for international beauty brands, including agreed INCI, quality, batch, stability and packaging-compatibility information. Brands can also explore private-label development, custom formulation and contact MOOYAM for project discussions.
Official sources
- FDA: Registration & Listing of Cosmetic Product Facilities and Products
- European Commission: Cosmetic Product Notification Portal
- GOV.UK: Making cosmetic products available in Great Britain
- Health Canada: Guide for Cosmetic Notifications
Last reviewed: 9 September 2026. Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.